Blue Trust Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
EAM
CGH
CUAMC
Blue Trust Inc's LKFT Position: Q2 2026 in Review
Blue Trust Inc opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 249 shares worth $7.46K. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings. This is a return to the name: Blue Trust Inc previously reported a position in LKFT as recently as Q3 2025.
Blue Trust Inc first reported a position in LKFT in Q3 2022 and has held it in 12 quarters since. The position peaked at $12.8K in Q3 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Blue Trust Inc held 249 shares of Lakefront Biotherapeutics American Depositary Shares worth $7.46K as of Q2 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Blue Trust Inc position in Q2 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1936 holding.
- Blue Trust Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2022 and has held it in 12 quarters since.
- Blue Trust Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $12.8K in Q3 2024.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.